What is Alyson Ridpath's NPI number?

Alyson Ridpath's National Provider Identifier (NPI) is 1992253892, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.

What is Alyson Ridpath's specialty?

Alyson Ridpath is listed in the NPPES registry with a primary specialty of Dermatology Physician (Allopathic & Osteopathic Physicians).

Where is Alyson Ridpath located?

Alyson Ridpath's practice location on file with NPPES is 6946 Forest Ave Ste 200, Richmond, VA 23230-1701.

What is Alyson Ridpath's phone number?

The practice phone number listed in the NPPES registry for Alyson Ridpath is (804) 285-2006.

Does Alyson Ridpath accept Medicare?

Alyson Ridpath is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.

Is Alyson Ridpath's NPI active?

Yes — Alyson Ridpath's NPI (1992253892) is active in the NPPES registry as of the last update on 2025-07-08.

IndividualActiveAccepts Medicare

Alyson Ridpath, D.O.

NPI 1992253892 · Dermatology Physician · Richmond, VA

Alyson Ridpath, D.O. is a Dermatology Physician provider in Richmond, VA (NPI 1992253892).

Provider details

NPI number: 1992253892
Entity type: Individual
Primary specialty: Dermatology PhysicianAllopathic & Osteopathic Physicians
Credential: D.O.
Sex: Female
Sole proprietor: No
License: 0102205674 (VA)

Practice location

6946 Forest Ave Ste 200

Richmond, VA 23230-1701

Phone: (804) 285-2006

Street-level locationGet directions

More VA providers

Mailing address

7201 Glen Forest Dr Ste 100

Richmond, VA 23226-3759

Specialties & taxonomies

Dermatology PhysicianPrimary207N00000XLicense 0102205674 (VA)
Allopathic & Osteopathic Physicians

Enrolled with Medicare as Practitioner - Dermatology · source: CMS PECOS Public Provider Enrollment (2026.04.01)

Profile Score

Detailed profile(82/100 index)

A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.

Registry tenure25% of score
10 yrs in NPPES registry
Profile completeness25% of score
100% of core fields populated
Practice footprint15% of score
1 documented practice location
Medicare service volume (vs. specialty peers)25% of score
11,173 Medicare services, 2024 (ranked within specialty)
Open Payments transparency10% of score
Has Open Payments disclosures (2024)

Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our methodology.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Destruction of Precancer Skin Growth, 2-14 Growths17003	3,691	$6
Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213	1,736	$88
Pathology Examination of Tissue Using a Microscope, Intermediate Complexity88305	1,163	$69
Destruction of Precancer Skin Growth, 1 Growth17000	1,145	$50
Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214	879	$125
Destruction of Skin Growth, 1-14 Growths17110

What this provider prescribes (Medicare Part D)

Top drugs by Medicare Part D claim volume, 2024 · 25 distinct drugs on file.

Drug	Part D claims (2024)	Beneficiaries
Ketoconazole	211	106
Clobetasol Propionate	157	106
Triamcinolone Acetonide	129	85
Metronidazole	73	35
Hydrocortisone	65	45
Fluorouracil	64	59
Fluocinonide	53	34
Valacyclovir Hclbrand: Valacyclovir	34

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$744 across 32 records (Open Payments 2024)

Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.

Enumerated: 2016-09-20
Last updated: 2025-07-08
Certified: 2025-07-08

Frequently asked questions

What is Alyson Ridpath's NPI number?: Alyson Ridpath's National Provider Identifier (NPI) is 1992253892, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
What is Alyson Ridpath's specialty?: Alyson Ridpath is listed in the NPPES registry with a primary specialty of Dermatology Physician (Allopathic & Osteopathic Physicians).
Where is Alyson Ridpath located?: Alyson Ridpath's practice location on file with NPPES is 6946 Forest Ave Ste 200, Richmond, VA 23230-1701.
What is Alyson Ridpath's phone number?: The practice phone number listed in the NPPES registry for Alyson Ridpath is (804) 285-2006.
Does Alyson Ridpath accept Medicare?: Alyson Ridpath is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
Is Alyson Ridpath's NPI active?: Yes — Alyson Ridpath's NPI (1992253892) is active in the NPPES registry as of the last update on 2025-07-08.

Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Destruction of Precancer Skin Growth, 2-14 Growths17003	3,691	$6
Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213	1,736	$88
Pathology Examination of Tissue Using a Microscope, Intermediate Complexity88305	1,163	$69
Destruction of Precancer Skin Growth, 1 Growth17000	1,145	$50
Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214	879	$125
Destruction of Skin Growth, 1-14 Growths17110

Drug

Part D claims (2024)

Beneficiaries

Ketoconazole

211

106

Clobetasol Propionate

157

106

Triamcinolone Acetonide

129

Metronidazole

Hydrocortisone

Fluorouracil

Fluocinonide

Valacyclovir Hclbrand: Valacyclovir

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$744 across 32 records (Open Payments 2024)

Provider details

Practice location

Mailing address

Specialties & taxonomies

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments

Registry dates

Frequently asked questions

Specialties & taxonomies

Frequently asked questions

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments